VSee Health divested its subsidiary VSee Lab to former co-CEO Milton Chen in exchange for shares, significantly narrowing projected net losses and leaving Dr. Imoigele Aisiku as the sole CEO. Concurrently, VisionWave Holdings agreed to acquire a 52% stake in Foresight Autonomous Holdings with a two-year value protection mechanism for the shares involved. Additionally, Visionary Holdings received a Nasdaq delisting notice and plans to appeal the decision before a formal hearings panel.
The company received a formal notice for failing to meet listing requirements and intends to request a hearing to challenge the decision.
Read the full storyVSee Health sold its VSee Lab unit to former co-CEO Milton Chen for 2.87 million shares, significantly narrowing pro forma net losses for 2025 and 2026.
VisionWave Holdings agreed to a 52% stake acquisition in Foresight Autonomous, featuring a two-year share value protection mechanism.